Cargando…

Reduction in anti-seizure medications use in pediatric patients with pharmacoresistant epilepsy submitted to surgical treatment

PURPOSE: We aimed to analyze the potential for postoperative (PO) medication suspension and reduction, emphasizing passive withdrawal. METHODS: Retrospective study of patients under 18 years old submitted to surgical treatment for pharmacoresistant epilepsy and classified as Engel I during the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Matos, Maiave Micaelle Figueiredo, Batista, Larissa Aparecida, Thomé, Ursula, Sakamoto, Américo Ceiki, Santos, Marcelo Volpon, Machado, Hélio Rubens, Wichert-Ana, Lauro, Hamad, Ana Paula Andrade
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798357/ https://www.ncbi.nlm.nih.gov/pubmed/36580119 http://dx.doi.org/10.1007/s00381-022-05812-0

Ejemplares similares

Pharmacoresistant seizures and IDH mutation in low-grade gliomas
por: Correia, Carlos Eduardo, et al.
Publicado: (2021)

Pharmacoresistant Abdominal Seizures in Symptomatic Localization-Related Epilepsy
por: Tushar, Vadakke Puthanveetil, et al.
Publicado: (2021)

Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)

Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020)

FALSE PHARMACORESISTANCE – A TRUE PROBLEM
por: Bašić, Silvio, et al.
Publicado: (2021)

Different pharmacoresistance of focal epileptic spasms, generalized epileptic spasms, and generalized epileptic spasms combined with focal seizures
por: Takahashi, Yukitoshi, et al.
Publicado: (2021)

Past Trauma Is Associated With a Higher Risk of Experiencing an Epileptic Seizure as Traumatic in Patients With Pharmacoresistant Focal Epilepsy
por: Mariotti, Sara, et al.
Publicado: (2021)

Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Long-Term Outcome of Temporal Lobe Epilepsy Surgery in 621 Patients With Hippocampal Sclerosis: Clinical and Surgical Prognostic Factors
por: Pereira Dalio, Marina Teixeira Ramalho, et al.
Publicado: (2022)

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder
por: Vyskocilova, Jana, et al.
Publicado: (2016)

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
por: Fattorusso, Antonella, et al.
Publicado: (2021)

Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
por: Czornyj, Liliana, et al.
Publicado: (2021)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Effect of diazepam on sociability of rats submitted to neonatal seizures
por: Leite, Ingrid Stanize, et al.
Publicado: (2016)

Inaugural seizure in a patient submitted to electroconvulsive therapy and anti-psychotic treatment: Who’s the culprit?
por: Figueiredo, I., et al.
Publicado: (2021)

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)

A complex systems view on the current hypotheses of epilepsy pharmacoresistance
por: Servilha‐Menezes, Gabriel, et al.
Publicado: (2022)

Functional Connectivity Derived From Electroencephalogram in Pharmacoresistant Epileptic Encephalopathy Using Cannabidiol as Adjunctive Antiepileptic Therapy
por: Morales Chacón, Lilia Maria, et al.
Publicado: (2021)

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy
por: Yoon, Jung-Rim, et al.
Publicado: (2013)

7T MRI with post-processing for the presurgical evaluation of pharmacoresistant focal epilepsy
por: Chen, Cong, et al.
Publicado: (2021)

‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy
por: Grote, Alexander, et al.
Publicado: (2022)

Limbic network co‐localization predicts pharmacoresistance in dysplasia‐related epilepsy
por: Cohen, Nathan T., et al.
Publicado: (2023)

The role of automated image co-registration and internal dosimetry in personalized medicine
por: Alexandre-Santos, Leonardo, et al.
Publicado: (2023)

A Novel Noninvasive Approach Based on SPECT and EEG for the Location of the Epileptogenic Zone in Pharmacoresistant Non-Lesional Epilepsy
por: Batista García-Ramó, Karla, et al.
Publicado: (2019)

Transcranial Magnetic Stimulation for the Treatment of Pharmacoresistant Nondelusional Auditory Verbal Hallucinations in Dementia
por: Marras, Anna, et al.
Publicado: (2013)

Effects of Surgical Side and Site on Mood and Behavior Outcome in Children with Pharmacoresistant Epilepsy
por: Andresen, Elizabeth N., et al.
Publicado: (2014)

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
por: Ociskova, Marie, et al.
Publicado: (2015)

Carbamazepine modulates the spatiotemporal activity in the dentate gyrus of rats and pharmacoresistant humans in vitro
por: Cappaert, Natalie L. M., et al.
Publicado: (2016)

Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
por: Contin, Manuela, et al.
Publicado: (2021)

Pharmacoresistant Epilepsy in Childhood: Think of the Cerebral Folate Deficiency, a Treatable Disease
por: Mafi, Sarah, et al.
Publicado: (2020)

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
por: El-Tallawy, Hamdy N, et al.
Publicado: (2021)

Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy
por: Torres Diaz, Cristina V., et al.
Publicado: (2021)

Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
por: Bruxel, Estela M., et al.
Publicado: (2021)

Maximum Phonation Time in People with Obesity Not Submitted or Submitted to Bariatric Surgery
por: Fonseca, Ana Luara Ferreura, et al.
Publicado: (2019)

Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions
por: Sharma, Arun Kumar, et al.
Publicado: (2015)

Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
por: Hoosain, Famida G., et al.
Publicado: (2015)

Bilateral stereotactic lesions and chronic stimulation of the anterior thalamic nuclei for treatment of pharmacoresistant epilepsy
por: Sitnikov, A. R., et al.
Publicado: (2018)

Transcranial Direct Current Stimulation for Patients With Pharmacoresistant Epileptic Spasms: A Pilot Study
por: Yang, Dongju, et al.
Publicado: (2019)

Altered structural connectome in non-lesional newly diagnosed focal epilepsy: Relation to pharmacoresistance
por: Kreilkamp, Barbara A.K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aoepf26r362rm366g4cdc9e79q